SSSelen Soylu

Selen Soylu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Selen Soylu has a total of 15 co-authors. Here are the top co-authors by number of shared publications:

  • Aysel Büşra Şişman

    Department of Neurology, Haseki Research and Training Hospital, Health Sciences University, Istanbul, Turkey

    1 shared publication
  • Birgül Baştan

    Clinic of Neurology, Haseki Training and Research Hospital, İstanbul, Turkey

    1 shared publication
  • Cem Ismail Kucukali

    Istanbul University, Aziz Sancar Institute of Experimental Medicine, Department of Neuroscience, Istanbul, Turkey

    1 shared publication
  • Ece Akbayır

    Istanbul University, Aziz Sancar Institute of Experimental Medicine, Department of Neuroscience, Istanbul, Turkey; Istanbul University, Institute of Graduate Studies in Health Sciences, Istanbul, Turkey

    1 shared publication
  • Elif Şanlı

    Istanbul University, Aziz Sancar Institute of Experimental Medicine, Department of Neuroscience, Istanbul, Turkey; Istanbul University, Institute of Graduate Studies in Health Sciences, Istanbul, Turkey

    1 shared publication
  • Erdem Tüzün

    Istanbul University, Aziz Sancar Institute of Experimental Medicine, Department of Neuroscience, Istanbul, Turkey

    1 shared publication

Latest Publications

  • Increased serum transferrin receptor 1 levels are associated with severity of acute ischemic stroke in patients with Covid-19 pneumonia

    by Zülfikar Memiş, Selen Soylu, Muhammet Duran Bayar, Aysel Büşra Şişman, Nuray Sancar, Erdem Tüzün, Birgül Baştan

    Background and purpose – Acute ischemic stroke (AIS) is often encountered during the clinical course of coronavirus disease 2019 (COVID-19) infection. Accumulated evidence has indicated involvement of ferroptosis in AIS. Our aim was to investigate the association between serum levels of ferroptosis markers and severity of AIS in COVID-19 patients. Methods – Twenty-nine consecutively enrolled COVID-19+ pneumonia patients with AIS due to middle cerebral artery (MCA) occlusion, 25 COVID-19+ pneumonia patients without AIS and 26 AIS patients without COVID-19 infection were included. Serum levels of ferroptosis markers glutathione peroxidase 4 (GPX4), dipeptidylpeptidase-4 (DPP4) and soluble transferrin receptor 1 (sTFR1) were measured by ELISA. Results – While serum GPX4 levels were comparable among groups, COVID-19 patients with and without AIS showed significantly increased serum sTFR1 levels and COVID-19 patients with AIS showed significantly decreased serum DPP4 levels. In patients with COVID-19 and AIS, serum levels of DPP4 and sTFR1 respectively showed negative and positive correlation with levels of D-dimer and/or C-reactive protein (CRP). Levels of ferroptosis markers did not correlate with clinical/prognostic features of pneumonia or AIS. Nevertheless, COVID-19 patients with higher (≥ 131 pg/ ml) sTFR1 levels were more likely to exhibit severe pneumonia, increased clinical severity of AIS (assessed by the national institutes of health stroke and modified Rankin scales) and elevated D-dimer/CRP levels. Our results indicate TFR1 as a potential role player in both COVID-19 pneumonia and arterial thrombosis associated with COVID-19 infection. The biomarker utility of sTFR1 in these disorders should further be evaluated. Conclusion – Our results suggest that AIS associated with COVID-19 have a different pathogenesis.

  • Distribution of peripheral blood mononuclear cell subtypes in patients with West syndrome: Impact of synacthen treatment

    by Selen Soylu, Minara Cherkezzade, Ece Akbayır, Hande Yüceer Korkmaz, Gizem Koral, Elif Şanlı, Pınar Topaloğlu, Vuslat Yılmaz, Erdem Tüzün, Cem İsmail Küçükali